Fig. 2: YTHDF1 promotes the cell cycle transition in PCa.
From: YTHDF1/RNF7/p27 axis promotes prostate cancer progression

The knockdown of YTHDF1 in DU145 cells significantly decreased the incorporation efficiency of BrdU, with (B) presenting the statistical analysis of (A). Scale bar = 100 μm. C Statistic results for the FACS analysis of YTHDF1 knockdown leading to an increased number of cells in the G0/G1 phase. D Immunoblot analysis demonstrated the changes in the expression of cell cycle-related proteins, including CDK2, CDK4, CDK6, and p27, following YTHDF1 knockdown. The overexpression of YTHDF1 in RWPE-1 cells was assessed, with (E) analyzing mRNA levels and (F) analyzing protein levels. The green arrow indicates exogenous YTHDF1-flag, while the black arrow denotes endogenous YTHDF1. G The overexpression of YTHDF1 in RWPE-1 cells enhances tumor cell growth. The overexpression of YTHDF1 in RWPE-1 cells increases BrdU incorporation efficiency, with (I) representing the statistical analysis of (H). Scale bar = 100 μm. J, K Organoid images derived from prostatic Pten and Tp53 knockout mice (Pten−/−; TP53−/−), with or without mouse mYTHDF1 knockdown. The statistical result was presented in (K) for (J). Organoid images derived from prostatic Pten knockout mice (Pten-/-), with or without YTHDF1 knockdown. The statistical result was presented in (M) for (L). N Images of xenograft tumors. O Silencing YTHDF1 resulted in reduced tumor volume. Immunohistochemical (IHC) analysis of xenograft tumors, including H&E staining and expressions of YTHDF1 and Ki67, with (Q) representing the statistical analysis of (P). YTH ove = YTHDF1 overexpression. Means ± SEM, *P < 0.05; **P < 0.01; ***P < 0.001; t-test.